Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Rev Mal Respir ; 41(3): 248-256, 2024 Mar.
Article in French | MEDLINE | ID: mdl-38320877

ABSTRACT

INTRODUCTION: Respiratory diseases represent a major public health issue and impact both quality of life and life expectancy of the patients. STATE OF ART: Several interventions used in respiratory physiotherapy have been shown to reduce dyspnoea, improve quality of life and reduce hospitalisation in many respiratory diseases. However, respiratory physiotherapy remains poorly known to the medical community and may be under-prescribed. PERSPECTIVES: In order to improve the interdisciplinarity around the patient with respiratory impairment, we describe the interests and prescription modalities of liberal respiratory physiotherapy. In the context of respiratory physiotherapy acts, the precision of drafting prescription directly conditions the means implemented by the physiotherapist regarding care provided to the patient. CONCLUSION: The increased knowledge of prescribers, both concerning the prescription methods and the precise content of the rehabilitation sessions is one of the keys to their success.


Subject(s)
Quality of Life , Respiratory Tract Diseases , Humans , Physical Therapy Modalities , Prescriptions , Private Practice , Respiratory Tract Diseases/therapy
2.
Int J Pharm ; 572: 118833, 2019 Dec 15.
Article in English | MEDLINE | ID: mdl-31715363

ABSTRACT

Different types of in-situ forming implants based on poly(lactic-co-glycolic acid) (PLGA) for the controlled dual release of an antiseptic drug (chlorhexidine) and an anti-inflammatory drug (ibuprofen) were prepared and thoroughly characterized in vitro. N-methyl-pyrrolidone (NMP) was used as water-miscible solvent, acetyltributyl citrate (ATBC) as plasticizer and hydroxypropyl methylcellulose (HPMC) was added to enhance the implants' stickiness/bioadhesion upon formation within the periodontal pocket. Different drug forms exhibiting substantially different solubilities were used: chlorhexidine dihydrochloride and digluconate as well as ibuprofen free acid and lysinate. The initial drug loadings were varied from 1.5 to 16.1%. In vitro drug release, dynamic changes in the pH of the surrounding bulk fluid and in the systems' wet mass as well as polymer degradation were monitored. Importantly, the release of both drugs, chlorhexidine and ibuprofen, could effectively be controlled simultaneously during several weeks. Interestingly, the tremendous differences in the drug forms' solubilities (e.g., factor >5000) did not translate into major differences in the resulting release kinetics. In the case of ibuprofen, this can likely (at least in part) be attributed to significant drug-polymer interactions (ibuprofen acts as a plasticizer for PLGA). In the case of chlorhexidine, the release of the much less soluble dihydrochloride was even faster compared to the more soluble digluconate (when combined with ibuprofen free acid). In the case of ibuprofen, at higher initial drug loadings also limited solubility effects within the implants seem to play a role, in contrast to chlorhexidine. In the latter case, instead, increased system porosity effects likely dominate at higher drug loadings.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Chlorhexidine/administration & dosage , Ibuprofen/administration & dosage , Adhesiveness , Anti-Infective Agents, Local/chemistry , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Chemistry, Pharmaceutical , Chlorhexidine/chemistry , Delayed-Action Preparations , Drug Combinations , Drug Implants , Drug Liberation , Excipients/chemistry , Ibuprofen/chemistry , Periodontal Diseases/drug therapy , Plasticizers/chemistry , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Porosity , Solubility , Solvents/chemistry
3.
Oral Dis ; 25(2): 385-402, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29377446

ABSTRACT

A systematic review and meta-analysis were conducted to evaluate the association between periodontitis (PD) and chronic kidney disease (CKD) and to explore the potential influence of periodontal treatment in patients with CKD. Databases (PubMed, Web of Science, Science direct, Cochrane Database) were screened for relevant articles, focusing on the periodontal status of patients with CKD, published until December 2017. Five hundred and fifty-three articles were identified, and 37 fulfilled the inclusion criteria and were considered in this systematic review. Seventeen articles were included in the meta-analysis and 7 in the review focusing on the impact of periodontal treatment. Most of the identified studies indicated an increased incidence of PD in patients with CKD. Meta-analysis showed an association between CKD and PD, and strength of this association was increased when severe PD was considered (OR = 2.39 (1.70-3.36)). The association could be observed even after adjustment for major CKD risk factors or use of precise diagnosis criteria (OR = 2.26 for severe PD (1.69-3.01)). Analysis of cohort studies indicated an incident rate ratio (IRR) of 1.73. Periodontitis is associated with CKD after multivariable adjustment. Further studies are necessary to determine whether prevention or treatment of PD can reduce the incidence and/or severity of CKD.


Subject(s)
Periodontitis/epidemiology , Periodontitis/therapy , Renal Insufficiency, Chronic/epidemiology , Humans , Incidence , Renal Insufficiency, Chronic/physiopathology , Risk Factors
4.
Oral Dis ; 23(3): 300-311, 2017 Apr.
Article in English | MEDLINE | ID: mdl-26945691

ABSTRACT

Regeneration of periodontal tissues is one of the main goals of periodontal therapy. However, current treatment, including surgical approach, use of membrane to allow maturation of all periodontal tissues, or use of enamel matrix derivatives, presents limitations in their indications and outcomes leading to the development of new tissue engineering strategies. Several cytokines are considered as key molecules during periodontal destruction process. However, their role during each phase of periodontal wound healing remains unclear. Control and modulation of the inflammatory response and especially, release of cytokines or activation/inhibition in a time- and spatial-controlled manner may be a potential perspective for periodontal tissue engineering. The aim of this review was to summarize the specific role of several cytokines during periodontal wound healing and the potential therapeutic interest of inflammatory modulation for periodontal regeneration especially related to the expression sequence of cytokines.


Subject(s)
Cytokines , Inflammation/drug therapy , Periodontium/physiology , Wound Healing , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Biological Products/therapeutic use , Cell Proliferation , Cytokines/antagonists & inhibitors , Guided Tissue Regeneration, Periodontal , Humans , Inflammation/metabolism , Regeneration
5.
Oral Dis ; 23(4): 424-439, 2017 May.
Article in English | MEDLINE | ID: mdl-27196369

ABSTRACT

Systemic sclerosis (SSc) is a rare multisystem connective tissue disorder characterized by the triad fibrosis, vasculopathy and immune dysregulation. This chronic disease has a significant impact on the orofacial region that is involved in more than two-thirds of the cases. SSc patients can show a wide array of oral manifestations, which are usually associated with a severe impairment of the quality of life. They often present a decreased the salivary flow and a reduced mouth opening that contribute substantially to the worsening of the oral health status. Therefore, SSc patients require specific and multidisciplinary interventions that should be initiated as early as possible. The identification of specific radiological and clinical signs at the early stage will improve the management of such patients. This study reviews the wide spectrum of orofacial manifestations associated with SSc and suggests clues for the oral management that remains challenging.


Subject(s)
Mouth Diseases/etiology , Scleroderma, Systemic/complications , Humans , Mouth Diseases/diagnosis , Mouth Diseases/physiopathology , Mouth Diseases/therapy , Scleroderma, Systemic/physiopathology
6.
J Oral Rehabil ; 40(1): 60-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22882663

ABSTRACT

Periodontal diseases are common chronic inflammatory diseases caused by pathogenic microorganisms colonising the subgingival area and inducing local and systemic elevations of pro-inflammatory cytokines resulting in tissue destruction. Apparition and evolution of periodontal diseases are influenced by many local or systemic risk factors. Psychological stress has been suggested as one of them and may negatively influence the outcome of periodontal treatment. However, mechanisms explaining the possible relationship between stress and increased susceptibility to periodontal disease remain poorly understood. Several stress markers are found in blood and saliva of patients with periodontal diseases and influence the development of periodontal diseases by several mechanisms including modifications of the inflammatory response and changes in the composition of the dental biofilm. The aim of this review is to provide an insight into the relationship between psychological stress and periodontal diseases.


Subject(s)
Periodontal Diseases , Stress, Psychological/complications , Biomarkers/analysis , Biomarkers/chemistry , Catecholamines/analysis , Chromogranin A/analysis , Disease Susceptibility , Humans , Hydrocortisone/analysis , Mouth Mucosa/microbiology , Neuropeptides/analysis , Periodontal Diseases/etiology , Periodontal Diseases/immunology , Periodontal Diseases/psychology , Risk Factors , Saliva/chemistry , Salivary alpha-Amylases/analysis
7.
Mol Oral Microbiol ; 27(3): 137-48, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22520384

ABSTRACT

Porphyromonas gingivalis infection and cathepsins protease upregulation are independently implicated in atherosclerosis worsening. In this study, we evaluated the effects of P. gingivalis infection and P. gingivalis -purified lipopolysaccharide (Pg-LPS) stimulation on the expression of cathepsin B (CATB) in endothelial cells (ECs). Analysis of the enzymatic activity and expression of CATB were investigated at the messenger RNA, protein and protein-phosphorylation levels. Effects of Toll-like receptors 2 and 4 blocking on CATB activity were also analysed. Our results showed that P. gingivalis and Pg-LPS significantly increased the activity of CATB but with different kinetics. The peak of CATB activity was observed 3 h after P. gingivalis infection but it appeared 48 h after Pg-LPS stimulation. The increase of CATB activity was related to its rapid tyrosine-dephosphorylation during P. gingivalis infection, whereas the levels of CATB messenger RNAs and proteins did not vary after P. gingivalis infection or Pg-LPS stimulation. Inhibition of Toll-like-receptors 2 and 4 differentially decreased P. gingivalis and Pg-LPS CATB activations. These results showed for the first time that P. gingivalis infection rapidly affects ECs and modulates CATB activity, whereas Pg-LPS effects appear to be delayed. This study suggests that direct infection of ECs by P. gingivalis may worsen atherosclerotic plaque formation via activation of the CATB pathway.


Subject(s)
Cathepsin B/drug effects , Endothelial Cells/enzymology , Endothelium, Vascular/enzymology , Lipopolysaccharides/pharmacology , Porphyromonas gingivalis/physiology , Bacteroidaceae Infections/enzymology , Cell Culture Techniques , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Endothelial Cells/drug effects , Endothelial Cells/microbiology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Enzyme Activation/drug effects , Humans , Immunoblotting , Phosphorylation , Protein-Tyrosine Kinases/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Toll-Like Receptor 2/antagonists & inhibitors , Toll-Like Receptor 4/antagonists & inhibitors , Umbilical Veins/cytology
8.
J Pregnancy ; 2011: 164654, 2011.
Article in English | MEDLINE | ID: mdl-22132334

ABSTRACT

For ten years, the incidence of preterm birth does not decrease in developed countries despite the promotion of public health programs. Many risk factors have been identified including ethnicity, age, tobacco, and infection. However, almost 50% of preterm birth causes remain unknown. The periodontal diseases are highly prevalent inflammatory and infectious diseases of tooth supporting tissues leading to an oral disability. They influence negatively general health worsening cardiovascular diseases and diabetes. Periodontal diseases have been also suspected to increase the rate of preterm birth, but data remain contradictory. The objective of this review is to present the principal results of epidemiological, biological, and interventional studies on the link between periodontal diseases and preterm birth. The conclusions of this work underline the importance for the physician/obstetrician to identify women at risk for preterm birth and to address these patients to dentist for periodontal examination and treatment in order to limit adverse pregnancy outcomes.


Subject(s)
Periodontal Diseases/complications , Periodontal Diseases/epidemiology , Pregnancy Complications, Infectious/epidemiology , Premature Birth/epidemiology , Premature Birth/etiology , Bacterial Infections/complications , Cytokines/blood , Female , Humans , Maternal-Fetal Exchange/immunology , Periodontal Diseases/blood , Periodontal Diseases/microbiology , Periodontal Diseases/therapy , Pregnancy , Pregnancy Complications, Infectious/blood , Pregnancy Complications, Infectious/microbiology , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL